Latest Breaking News On - மகர ஆரோக்கியம் - Page 2 : comparemela.com
Ramalan Zodiak Capricorn, Aquarius, Pisces 24 Juni 2021: Pelukan Sederhana dapat Memberikan Keajaiban
pikiran-rakyat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pikiran-rakyat.com Daily Mail and Mail on Sunday newspapers.
Lupin receives UK marketing authorisation for Luforbec® 100/6 pMDI, first branded generic alternative to Fostair® to treat Asthma & COPD
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
КЪСМЕТЧЕ за 12 май според зодията
actualno.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from actualno.com Daily Mail and Mail on Sunday newspapers.
Theramex: Real world evidence demonstrates that risedronate GR (Actonel GR) has superior outcomes for fracture risk reduction in patients with osteoporosis compared to immediate release oral bisphosphonates
17% lower incidence of fracture, regardless of the fracture site (p1
29% reduction in the incidence of spine fractures (p=0.05)
1
Time to first fracture was delayed for the risedronate GR cohort, reaching statistical significance at 36 months (p=0.037)
1
A real world evidence study, presented at the 13
th International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders has shown for the first time via direct comparison, that risedronate GR (Actonel GR) demonstrated superior outcomes for fracture risk reduction in patients with osteoporosis, compared to those who received an immediate release (IR) bisphosphonate.
(2)
Press Release for European Medical and Trade Media Only
BIAL announces the end of the licence agreement established in 2009. BIAL takes the lead for the marketing and distribution of Zebinix (eslicarbazepine acetate) in Europe. Eslicarbazepine acetate is a once-daily anti-epileptic used to treat epilepsy patients with focal seizures (partial-onset seizures)
For over a decade, BIAL and Eisai have had an agreement in place for Eisai to market, promote, and distribute eslicarbazepine acetate in Europe. Following the end of this partnership, BIAL will take the lead for the ongoing marketing, promotion and distribution in Europe. This move reinforces its continued commitment to and ongoing investment in neurological conditions.